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Background: Redo-sternotomy for mitral valve (MV) surgery may be complex and attendant complications can be
avoided using anterolateral right thoracotomy, deep hypothermia (20°C, nasopharyngeal) with low flow
cardiopulmonary perfusion. Video-assisted minithoracotomy technique is a further improvement.
Methods: We performed 20 consecutive MV operations in patients with previous cardiac surgery using video-assisted
right minithoracotomy, femoro-femoral bypass, deep hypothermia, low flow cardiopulmonary bypass without aortic
cross-clamping. The mean follow-up was 30 ± 17.8 mo. Data is presented as the mean ± standard deviation of the mean.
Results: There were 11 males and 9 females (age, 62.3 ± 12.1; ejection fraction 50.1 ± 11.2). Operations included MV
replacement (n = 11), MV repair (n = 5), and MV re-replacement (n = 4). There were no hospital deaths, and the mean
hospital stay was 8 ± 2.9 days. There were no postoperative strokes or need for mechanical circulatory support. The mean
cardiopulmonary bypass time was 152 ± 28 minutes. Two patients (10%) required inotropic support beyond 24 hrs. All
patients were free from inotropic support at 48 hours. The mean number of transfused red cell units was 2.8 ± 0.8 (range,
2 to 4). One patient died in another institution six months postoperatively following surgery for acute type III aortic
dissection. At 30 ± 17.8 months follow-up all patients were found to be in NYHA Class I or II.
Conclusions: Minimally invasive video-assisted MV surgery using deep hypothermia, low-flow cardiopulmonary bypass
without aortic clamping can result in excellent clinical outcomes in patients with previous cardiac surgery via a median
sternotomy. This technique offers reproducible results, good myocardial protection (as evidenced by the low rate of
inotropic support that patients needed postoperatively), and low rates of complications.
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In patients with previous cardiac operations, there are
well-known risks of repeat median sternotomy, including
excessive bleeding, mediastinitis, cardiac tamponade, de-
hiscence, sternal osteomyelitis, and injury to cardiac
structures and/or patent coronary grafts [1,2]. These
complications mostly relate to the surgical trauma to the
densely healed sternum and dissection of the intense ad-
hesions surrounding the heart and coronary arteries,
with or without previous bypass grafts. As an alternative* Correspondence: htkiziltan@yahoo.com
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risks — right thoracotomy, femoro-femoral bypass, and
deep hypothermia with low flow perfusion were intro-
duced into clinical practice as a means of approaching
the mitral valve (MV) during reoperative surgery [3-5].
Many utilized right thoracotomy in reoperative MV pro-
cedures with favorable results [6-8]. A video-assisted
minithoracotomy technique has also been applied in this
context as a means of less invasive surgery [8-13].
With the premise of less tissue damage and improved
results on a difficult group of patients, we embarked on a
program of performing MV surgery using video-assisted
right minithoracotomy, deep hypothermia, low flow car-
diopulmonary bypass (CPB), and no-aortic clamping in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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our indications, technique, and results on this contempor-
ary management strategy.
Methods
Over the years, our group has performed video-assisted
minimally invasive MV surgery on more than 300 pa-
tients [14]. This study concerns a consecutive group of
20 of those 300 patients, all 20 of whom had prior ster-
notomies and subsequently underwent the reoperative
MV procedure between August 2009 and December
2013 using the same technique. The study was approved
by the institutional review boards of our hospitals and
an informed consent was obtained from all patients. In-
cluded in our study were all patients undergoing isolated
mitral or mitral/tricuspid valve surgery with trivial or
less aortic insufficiency. All patients underwent a com-
puterized tomography (CT) to ascertain risk of CPB via
femoral cannulation and rule out aortoiliac aneurysm
with thrombus formation. One patient with known de-
scending thoracic aneurysm underwent CT angiography
to exclude aortic dissection.
Three surgeons performed the operations in this study
while at least two of them actively participated for each
case. After induction of general anesthesia and single
lumen endotracheal intubation, a slight lateral decubitus
position was given to the patients. In all patients, a
transesophageal echocardiography (TEE) probe was
inserted at this stage of the operation and TEE was per-
formed to evaluate overall cardiac and valvular func-
tions. In particular, the feasibility of MV repair was
explored [15]. Our surgical technique included a small
(5 cm) right fourth intercostal space incision and two
thoracic ports at the anterior axillary line for the video cam-
era, cardiotomy vent, and CO2 insufflation ― 2 L/min ―
catheter. Intercostal muscles longer than the corresponding
skin incision were dissected. A specially designed rib
spreader (Estech, San Ramon, California) and a left atrial
retractor (with a supporting arm) passing through the thor-
acic wall were used. A small (4 cm) femoral fold incision
was performed. Direct arterial cannulation method ― fem-
oral artery snared over the cannula at proximal and
clamped at distal part― was utilized in all patients. A fem-
oral arterial (17 Fr, Medtronic, MN, USA) and a long ven-
ous cannula (30/33 Fr, Medtronic) were inserted for
femoro-femoral CPB. Additionally, a transcutaneous in-
ternal jugular venous cannula (17 Fr, Medtronic, MN,
USA) (n = 3) and a separate superior vena cava cannula
(n = 1) were utilized for satisfactory venous return. Vena
cavae were snared (n = 2) in patients with planned tricuspid
valve repair. During CPB, patients were cooled down to
20°C. The pericardium was opened 2 cm above the
phrenic nerve and a left atrial incision was performed be-
tween right pulmonary veins and interatrial groove. TheCPB flow was reduced as the hypothermia progressed, and
exposure of the MV succeeded accordingly. On CPB, pa-
tients developed ventricular fibrillation spontaneously.
Once 20°C was reached, excepting infrequent periods of
very low CPB perfusion flow (near circulatory arrest) so as
to improve MV visualization, minimal CPB flow was 1.5
liter/min. As a general rule, blood pressure above 70 to
80 mmHg was maintained during CPB. Dysfunctional na-
tive (n = 11) or prosthetic valves (n = 4) were explanted
and prosthetic valves implanted using interrupted mat-
tress sutures. In 8 patients (7 ischemic MI and 1 AVSD
patient) undergoing MV replacement (MVR), the poster-
ior MV and chordae were spared. In 3 patients with ische-
mic MI who also had mitral stenosis, non-chordal sparing
MVR was performed. 2 of the 4 patients undergoing MV
re-replacement had their posterior MV and chordae intact,
and these were spared, too. Five patients received MV re-
pair (chordal replacement, n = 1) with an annuloplasty
(downsizing) ring (n = 5). Rewarming was started. The
right atrium was opened with the vena cavae snared in
two patients and tricuspid repair with an annuloplasty ring
was performed. The right atrium was closed. Under in-
creased CO2 insufflation ― 8 L/min ―, an 8 Fr venting
catheter was introduced into the left ventricle through the
valve, the patient was given a slight Trendelenburg and
leftward position, and air was meticulously evacuated. The
left atrium was closed, rewarming was completed, and the
heart was defibrillated using externally placed electrodes.
The patient was placed on partial CPB with a left ventricu-
lar catheter in place, as previously described [5] to keep
one of the mitral prosthetic leaflets incompetent. This
methodology allowed air and possible debris to be evacu-
ated through the vent without entering into the systemic
circulation. The venting catheter was removed, and pa-
tients were then weaned from CPB only after ensuring
the absence of left ventricular air at the TEE. Right ven-
tricular pacing wires were placed. Chest tubes were
inserted in the right side and inside the pericardium,
and the chest was closed. Postoperatively, patients
underwent at least one pre-discharge echocardiography
which was also performed every 6 mo. after discharge.
The patients’ hospital charts were reviewed and a re-
cent follow-up which included echocardiographic evalu-
ation of the valvular function was obtained. Data is
presented as the mean ± standard deviation of the mean.
Results
The demographic and preoperative characteristics of the
patients are summarized in Table 1. The main indication
for surgery was congestive heart failure. All patients
were in New York Heart Association (NYHA) Class III
or IV. Severe disabling hemolytic anemia and congestive
heart failure with ascites due to severe paravalvular leak
were found in one patient who had undergone MVR
Table 1 Demographic and preoperative patient
characteristics
Variable Mean ± SD or no
Age 62 ± 12 (28–79) years
Sex 11 male, 9 female
Functional class
NYHA class III 12
NYHA class IV 8
EF 50 ± 11
EF≥ 50% 13
EF < 50% 7
MI 13
MS 1





CABG and AVR 1
CABG and bioprosthetic MVR 1
MVR (mechanical) 2
MVR (bioprosthetic) 1
Partial AVSD repair 1
NYHA: New York Heart Association; EF: Ejection fraction; MI: Mitral valve
Insufficiency; MS: Mitral valve stenosis; CABG: Coronary artery bypass grafting;
AVR: Aortic valve replacement; MVR: Mitral valve replacement: AVSD:
Atrioventricular septal defect.
Table 2 Operative and postoperative data






Cardiopulmonary bypass time 152 ± 28 min
Intensive care unit stay 2,4 ± 1 days
No. of red cell transfusion 2,8 ± 0,8
Inotropic support (early postoperative period) 5 patients
Inotropic support (beyond 24 h) 2 patients
IABP requirement None
Postoperative stroke or neurologic dysfunction None
Hospital stay 8,1 ± 2,9 days
Follow-up time 30 ± 17.8 mo
*Note that tricuspid plasty was performed as a concomitant procedure in two
patients undergoing MVR. MV: Mitral valve; IABP: Intra-aortic balloon pump.
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lar septal defect (AVSD) repair (n = 1), coronary artery
bypass grafting (CABG) and aortic valve replacement
(AVR) (n = 1), CABG and MVR (n = 1), MVR (n = 3),
and CABG (n = 14). All patients with previous CABG
operations (n = 16) had functioning internal thoracic ar-
tery (ITA) grafts. We did not have patent ITAs intimately
stuck to the posterior sternal table in this series of patients
which would constitute an absolute anatomical contra-
indication to a redo sternotomy. In seven patients there
was a patent graft to the right coronary artery originating
from the aorta which would have been at risk of damage.
Operative and postoperative data are summarized in
Table 2. The indications for MV surgery were ischemic
MV insufficiency (n = 12, all with annular dilatation, 11
of which patients had restricted posterior leaflet motion,
while the remaining patient had elongated papillary
muscles), paravalvular leak in a previously implanted
mechanical prosthesis (n = 2), bioprosthetic MV insuffi-
ciency (n = 2), rheumatic mitral stenosis (n = 3) and a
mitral cleft causing valvular insufficiency in a partial
AVSD (n = 1). Exposure of the MV was satisfactory in all
cases — though the MV position was slightly deeper in
the thoracic cavity — and no patient required aconversion to a median sternotomy. MVR (n = 15) and
repair (n = 5) were performed. All patients survived the
operation. The mean CPB time was 152 ± 28 minutes
(range, 112 to 200). There were three patients with atrial
fibrillation. Ablation surgery for atrial fibrillation was
not considered for two reasons for these patients: reo-
perative surgery and left atrial diameter > 5.5 cm. Five
patients ― 3 MVR (1 also having TP), 2 MV re-
replacement; mean EF 46%; all having non-chordal spar-
ing MVR ― required a low level of inotropic support in
the first 24 hours postoperatively. Two of these contin-
ued receiving the support beyond that period. All five
were completely weaned off the inotropes at 48 hours.
None of these patients required pulmonary artery catheter
monitoring to assess cardiac output and/or immediate
postoperative echocardiography. On the fifth postoperative
day, a 78-year-old woman with peripheral arterial disease
and a calcified femoral artery developed femoral artery
thrombosis at the femoral artery incision. This patient had
also undergone a direct femoral artery cannulation, as had
all other patients in this series. A thromboembolectomy
was performed and, after excising the 4 cm portion of the
artery, an 8 mm Dacron graft was interposed in the fem-
oral artery due to localized dissection and poor arterial
quality. She also developed groin infection, and required a
local surgery, and then recovered uneventfully. Another
patient developed femoral hematoma seven days postoper-
atively and required evacuation of the hematoma. One
patient developed right diaphragmatic elevation on
CXR postoperatively; the patient has been clinically
asymptomatic. No other complications such as stroke,
low cardiac output, myocardial infarction, prosthetic
Kızıltan et al. Journal of Cardiothoracic Surgery  (2015) 10:55 Page 4 of 6valve endocarditis, pleural effusion, pneumothorax or
pneumonia have been observed. Preoperative screening
using CT demonstrated 5.3 cm descending thoracic
aneurysm without thrombus formation in a 63-year-old
patient who had previously undergone CABG. Having pa-
tent four-vessel bypass grafts with functioning ITA, this
patient underwent a successful MVR utilizing femoral ar-
tery cannulation without experiencing postoperative
neurologic dysfunction. We did not consider concomitant
or endovascular aneurysm repair shortly after his oper-
ation before his aneurysm diameter reached 5.5 cm. The
follow-up showed that he died in another institution six
months postoperatively following surgery for acute type
III aortic dissection. All patients had echocardiographic
evaluation showing good valvular function and the pa-
tients receiving mechanical valves were anticoagulated
using Warfarin before hospital discharge. Recent follow-
up data were collected including echocardiographic evalu-
ation (mean 30 ± 17.8 mo, range, 11 to 64). All patients
were found to be in NYHA Class I or II. One patient with
mitral repair was found to have moderate mitral insuffi-
ciency and NYHA Class II functional capacity.
Discussion
Our study involved 20 consecutive patients undergoing
MV surgery after previous cardiac surgery/sternotomy
via right thoracic minimally invasive access, deep
hypothermic low flow CPB, and no aortic clamping. We
have seen neither mortality nor neurologic dysfunction.
Advancing surgical techniques and blood conservation
methodologies made reoperative cardiac surgery using
repeat median sternotomy a common practice, with the
resulting morbidity and mortality both low [16,17].
However, patients with previous CABG, especially ones
with patent ITA grafts, remained a group posing dangers
and necessitating caution — even for teams with a fad-
ing enthusiasm for right thoracotomy [16] — during a
sternal reentry for MVR. Seeburger reported 6.6% mor-
tality and 5.2% neurologic impairment rates in his article
including 181 consecutive patients, where ventricular
fibrillation was utilized in 140 of them at 28°C [8].
Casselmann experienced 3.8% mortality and 2.5% stroke
rates in 80 consecutive similar cases undergoing endo-
scopic mitral and tricuspid surgery [11]. Even though
these minimally invasive studies—as well as others
[10,12,13] — report good results on a larger group of pa-
tients, such studies do not report the results of the exact
same technique on their patients that we applied. There-
fore, we hereby report our results, which strictly include
video-assisted minithoracotomy, deep hypothermia, and
low flow perfusion.
In Svenson’s study [18], comparing operative risks of a
right thoracotomy versus sternal-reentry stroke rate was
higher in right thoracotomy and right thoracotomyemerged as a risk factor for MVR. Several concerns
raised by the authors included quality of mitral exposure
and myocardial protection, and possible problems with
peripheral arterial cannulation. In the same study, five
out of the six strokes were found to be embolic in origin.
Svenson [18] argued that the heart needs to be continu-
ously fibrillating during the procedure in order to pre-
vent an air embolism whose risk might be increased by
any spontaneous conversion to regular cardiac contrac-
tions. Although it cannot be ruled out completely, if a
spontaneous conversion to cardiac contractions occurs,
this complication seems unlikely to us given the fact that
left ventricular ejection would be into the low-resistance
left atrial cavity because of the absence of a competent
mitral valve, and presence of systemic high resistance
above the competent aortic valve. Once the procedure is
completed, however, the MV should be kept incompe-
tent with a catheter passing through it. Experience
shows that this complication is not a common finding
[4-7], yet, it is not unseen [8]. Myocardial protection
with fibrillatory arrest in the setting of deep hypothermia
is satisfactory according to many others [4,6,7], our
group among them. Svenson stressed in his article that
right thoracotomy frequently afforded somewhat limited
mitral exposure and a potentially reduced probability of
MV repair [18]; we agree with this comment, as in only
five (out of 16) patients were we able to perform a mitral
repair. In our experience, this is partially attributable to
the fact that the MV is positioned deeply in the thoracic
cavity far from the operator. In addition, this technique
involves deep hypothermia, and therefore a failed mitral
repair on the postoperative TEE would necessitate an
additional long period of CPB — including cooling and
rewarming — to address the problem. This causes the
surgeon to abandon the repair due to the reduced prob-
ability of a satisfactory outcome. Nonetheless, there are
reports that the majority of the patients underwent mi-
tral repair utilizing a similar technique [8,19]. In our
series, four patients had re-replacement of the mitral
valve. One patient had partial AVSD and three had
rheumatic pathology; none of these eight was amenable
for repair. In the remaining 12 patients (all with previous
CABG), five (42% of the 12 patients, 25% of the total 20,
with a mean EF of 47%) had MV repair. One of the last
seven of our patients had a previous MVR. Of the
remaining six of those seven, half of them (50%) had mi-
tral repair, compared with 42% (the five of 12 mentioned
above). We believe our increased confidence in this
technique made us more liberal in MV repair, which ac-
counts for our elevated use of the procedure. Our
current concept on mitral repair when using this opera-
tive methodology is to keep it for the one who would
less likely fail on postoperative TEE, based on the find-
ings on preoperative TEE [15].
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MV intervention is a possible disturbance in the visibil-
ity of the MV due to back-bleeding. Murzi et al. used
the Port-Access system with endoaortic balloon clamp-
ing and antegrade cardioplegia delivery to overcome this
problem in patients with mild to moderate aortic insuffi-
ciency [10]. They mentioned using “additional doses of
cardioplegia and deeper cooling to obtain satisfactory
myocardial recovery since a significant portion of ante-
grade cardioplegia may go into the left ventricle”. How-
ever, in our view, this maneuver carries the risks of
nonuniform cardioplegia delivery into the myocardium
due to occlusion of the coronary graft ostia by the endo-
clamp, as well as cardioplegia wash-out by the function-
ing ITA, and may not be applicable at all in patients
with previous CABG. Instead, short periods of very low
CPB perfusion flow ― 0.2 to 0.5 liters/min ― can be
helpful to improve visibility when bleeding is excessive.
We try to restrict these occasions to the periods during
which a more clear vision of MV annulus is absolutely
necessary to put the stitch through. Those moments are
kept as short as possible ― less than few minutes ―
and immediately then blood flow is generally kept at or
above 1.5 liters/min.
Patients with previous thoracotomies who have thick
pleurae generally require extensive dissection on the
lungs, which may implicate a heavy risk for postopera-
tive pulmonary function [10,16]; for this reason, they too
may not be suitable candidates for this operation. Since
the initiation of our minimally invasive right thoracot-
omy procedures, we have seen patients with pleural
thickness as well as pleural adhesion. We currently do
not consider such patients for right thoracotomy so as
to avoid the postoperative pulmonary dysfunction. Be-
cause adhesion is generally undetectable on preoperative
imaging studies, during the operation, we prefer making
a very small thoracostomy just big enough to pass a fin-
ger through before progressing to a minithoracotomy in-
cision. If there is adhesion, we convert to sternotomy.
Therefore, in our view, considering the patients with
isolated reoperative MV pathologies, a more-than-
trivial aortic regurgitation and either pleural thickness or
pleural adhesion are the conditions for which right thora-
cotomy for mitral surgery should not be contemplated.
Our results are comparable with results in other reports
considering the postoperative blood loss, the number of
transfused red cells, and the duration of intensive care unit
and hospital stays [10,11]. So far, we are extremely pleased
with our results, as no neurological complications oc-
curred and low-output cardiac state was low with only 3
requiring inotropic support less than 24 hrs and 2 requir-
ing support between 24–48 hrs. There was no profound
low-output cardiac state as evidenced by the absence of
mechanical circulatory support.A 63-year-old patient with a 5.3 cm descending thoracic
aneurysm died 6 mo postoperatively during an operation
in another institution; his death was due to acute type III
aortic dissection. He was scheduled for imaging studies to
monitor the diameter of his descending aortic aneurysm.
Preoperatively, he had hypertension, a mildly elevated
blood creatinine level (1.6 mg/dL) and no known connect-
ive tissue disorder. Our strategy in patients with descend-
ing thoracic aneurysms is to consider endovascular repair
once the aneurysm diameter reaches 5.5 cm.
We have both femoral and axillary arterial cannula-
tions in our armamentarium, both with and without a
Dacron sidearm. Concerning the 78-year-old woman
who had thrombosis postoperatively in her femoral ar-
tery, even though it was observed preoperatively to be
normal in CT study, the wall of that artery was found to
be moderately calcified and she had known peripheral
arterial disease distal to the femoral artery, so in retro-
spect we consider an axillary artery cannulation to be a
better option in such circumstances.
Low incidence of inotropic need in our patients is con-
sistent with the experience found in the literature that
this technique provides very good myocardial protection
[4-7]. Excluding the patients with peripheral arterial
complications, the mean number of transfused red cell
was 2.25 ± 0.7 (range, 2 to 4), and the mean hospital stay
was 6.8 ± 0.8 days (range, 6 to 8).
The retrospective nature of this study and absence of
data from a randomized control group (a sternal re-
entry group) may restrict the accuracy of conclusions
that can be drawn from the study.
Conclusions
Based on our experience, we conclude that minimally inva-
sive video-assisted MV surgery utilizing deep hypothermia,
low-flow CPB without aortic clamping offers, more direct
access to the MV and clinically, good myocardial protec-
tion, reproducible results, and relatively low rates of com-
plications in patients with previous cardiac surgery via
median sternotomy.
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